COMPENDIUM ON FUNCTIONAL MEDICINE - Flipbook - Page 723
[201] Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3+
regulatory T cells in the human immune system. Nat Rev Immunol.
2010;10(7):490-500.
[202] Vignali DAA, Collison LW, Workman CJ. How regulatory T cells
work. Nat Rev Immunol. 2008;8(7):523-532.
[203] Mills KH. Regulatory T cells: friend or foe in immunity to
infection? Nat Rev Immunol. 2004;4(11):841-855.
[204] Shevach EM. Mechanisms of foxp3+ T regulatory
cell-mediated suppression. Immunity. 2009;30(5):636-645.
[205] Serhan CN. Pro-resolving lipid mediators are leads for
resolution physiology. Nature. 2014;510(7503):92-101.
[206] Gilroy DW, Bishop-Bailey D. Lipid mediators in immune
regulation and resolution. Br J Pharmacol. 2019;176(8):1009-1023.
[207] Wherry EJ, Kurachi M. Molecular and cellular insights into T
cell exhaustion. Nat Rev Immunol. 2015;15(8):486-499.
[208] Blank CU, Haining WN, Held W, et al. Defining 'T cell
exhaustion'. Nat Rev Immunol. 2019;19(11):665-674.
[209] Vojdani A. A comprehensive approach to assessing immune
status using lymphocyte subset analysis. Clin Rev Allergy Immunol.
2014;46(3):223-230.
[210] Maecker HT, McCoy JP, Nussenblatt R. Standardizing
immunophenotyping for the Human Immunology Project. Nat Rev
Immunol. 2012;12(3):191-200.
[211] Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and
implications for health and disease. Altern Med Rev.
2003;8(3):223-246.
[212] Spellberg B, Edwards JE Jr. Type 1/Type 2 immunity in
infectious diseases. Clin Infect Dis. 2001;32(1):76-102.
723
